Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Agilon Health (AGL) Short Interest Ratio & Short Volume

Agilon Health logo
$84.65 +4.08 (+5.06%)
As of 03:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Agilon Health Short Interest Overview

As of April 30, 2026, Agilon Health (AGL) had a short interest of 791,524 shares sold short, representing 4.86% of the public float. This marks a -20.91% decrease in short interest since the prior report. The short interest ratio (days to cover) is 1.9, meaning it would take 1.9 days of the average trading volume of 367,384 shares to cover all short positions.

Current Short Interest
791,524 shares
Previous Short Interest
1,000,735 shares
Change Vs. Previous Month
-20.91%
Dollar Volume Sold Short
$22.15 million
Short Interest Ratio
1.9 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
16,680,000 shares
Short Percent of Float
4.86%
Today's Trading Volume
248,720 shares
Average Trading Volume
367,384 shares
Today's Volume Vs. Average
68%
Short Selling Agilon Health?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Agilon Health and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AGL Short Interest Over Time

AGL Days to Cover Over Time

AGL Percentage of Float Shorted Over Time

Agilon Health Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2026791,524 shares $22.15 million -20.9%4.9%1.85 $27.99
4/15/20261,000,735 shares $26.96 million -26.3%6.2%2.28 $26.94
3/31/20261,357,594 shares $10.80 million -94.9%8.4%7.08 $7.96
3/13/202626,654,381 shares $16.13 million +8.4%6.6%5.39 $0.61
2/27/202624,591,484 shares $14.46 million +20.5%6.1%3.28 $0.59
2/13/202620,413,986 shares $7.37 million +1.2%5.0%1.85 $0.36
1/30/202620,177,282 shares $16.85 million -1.1%5.0%3.46 $0.84
1/15/202620,406,494 shares $20.71 million +5.2%5.1%2.93 $1.02
12/31/202519,389,860 shares $13.35 million -6.1%4.9%4.07 $0.69
12/15/202520,639,623 shares $13.68 million +15.1%5.2%2.35 $0.66
11/28/202517,931,905 shares $11.92 million -13.8%4.5%1.39 $0.67
11/14/202520,803,215 shares $11.96 million -0.4%5.2%1.42 $0.58
10/31/202520,881,325 shares $16.58 million +2.4%5.2%3.07 $0.79
10/15/202520,400,000 shares $20.71 million +3.1%6.7%1.8 $1.02
9/30/202519,790,000 shares $20.38 million -13.2%6.5%1.9 $1.03
9/15/202522,790,000 shares $25.41 million +25.4%7.5%2.2 $1.12
8/31/202518,170,000 shares $23.17 million -4.9%6.0%1.9 $1.28
8/15/202519,110,000 shares $21.21 million +1.0%6.3%2.1 $1.11
7/31/202518,920,000 shares $33.77 million +6.2%6.2%2.3 $1.79
7/15/202517,820,000 shares $39.11 million -14.5%5.9%4.4 $2.20
6/30/202520,840,000 shares $48.14 million -1.8%6.9%4.1 $2.31
6/15/202521,230,000 shares $45.75 million +5.8%7.0%4.1 $2.16
5/31/202520,070,000 shares $44.56 million -9.6%6.6%3.6 $2.22
5/15/202522,200,000 shares $56.61 million +1.1%7.3%3.6 $2.55
4/30/202521,960,000 shares $93.55 million +14.8%7.3%3.6 $4.26
4/15/202519,130,000 shares $105.88 million +4.7%6.3%3.2 $5.54
3/31/202518,270,000 shares $79.02 million -1.6%6.1%3.1 $4.33
3/15/202518,560,000 shares $75.63 million +10.3%6.1%3.4 $4.08
2/28/202516,820,000 shares $52.48 million -9.1%5.5%3.4 $3.12
2/15/202518,500,000 shares $63.36 million -8.6%6.1%4 $3.43
1/31/202520,240,000 shares $67.70 million -19.8%6.7%4.5 $3.35
1/15/202525,250,000 shares $71.46 million -9.0%8.3%5.9 $2.83
12/31/202427,760,000 shares $52.74 million -6.8%9.2%6.9 $1.90
12/15/202429,790,000 shares $66.73 million -6.7%9.8%6.8 $2.24
11/30/202431,940,000 shares $66.75 million +5.1%10.5%7 $2.09
11/15/202430,390,000 shares $48.17 million -16.1%10.0%6.4 $1.59
10/31/202436,220,000 shares $92.54 million +1.0%12.0%7.9 $2.56
10/15/202435,880,000 shares $119.12 million -1.7%11.9%8.2 $3.32
9/30/202436,490,000 shares $143.41 million -7.4%12.1%8.3 $3.93
9/15/202439,420,000 shares $139.15 million -4.2%13.0%8.3 $3.53
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)

When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.tc pixel

See the stock Musk's own words pointed to right here
8/31/202441,150,000 shares $167.89 million +6.3%13.6%9 $4.08
8/15/202438,700,000 shares $190.79 million -12.3%12.8%8.8 $4.93
7/31/202444,140,000 shares $304.35 million -3.8%14.6%9.7 $6.90
7/15/202445,860,000 shares $299.92 million +5.9%15.2%10.3 $6.54
6/30/202443,310,000 shares $283.25 million -0.7%14.3%9.8 $6.54
6/15/202443,620,000 shares $300.98 million -0.6%14.4%10.7 $6.90
5/31/202443,890,000 shares $276.51 million -1.7%14.5%10.4 $6.30
5/15/202444,660,000 shares $236.70 million +0.9%14.7%9.7 $5.30
4/30/202444,280,000 shares $243.32 million -3.8%14.6%9.3 $5.50
4/15/202446,020,000 shares $205.25 million -2.1%15.3%8.9 $4.46
3/31/202447,020,000 shares $286.82 million +0.1%15.5%7.7 $6.10
3/15/202446,960,000 shares $250.06 million -2.1%15.5%8 $5.33
2/29/202447,970,000 shares $293.10 million +4.0%15.9%8.7 $6.11
2/15/202446,120,000 shares $334.37 million +3.1%15.4%8.8 $7.25
1/31/202444,750,000 shares $263.80 million -5.8%15.0%8.6 $5.90
1/15/202447,490,000 shares $350.48 million +4.2%15.9%10.3 $7.38
12/31/202345,590,000 shares $572.15 million -3.2%15.2%11.6 $12.55
12/15/202347,090,000 shares $615.94 million -3.9%15.7%14.9 $13.08
11/30/202348,980,000 shares $520.17 million -0.7%16.3%16.4 $10.62
11/15/202349,330,000 shares $616.13 million +6.4%16.4%17.8 $12.49
10/31/202346,380,000 shares $834.84 million +4.0%15.5%18.9 $18.00
10/15/202344,590,000 shares $809.31 million +1.6%14.9%20.4 $18.15
9/30/202343,880,000 shares $779.31 million +3.2%14.6%18.8 $17.76
9/15/202342,520,000 shares $797.25 million +5.8%14.2%18.2 $18.75
8/31/202340,190,000 shares $712.17 million +10.5%13.3%15.2 $17.72
8/15/202336,380,000 shares $665.03 million -4.5%12.0%12.8 $18.28
7/31/202338,080,000 shares $729.42 million -3.2%12.6%10.6 $19.16
7/15/202339,320,000 shares $656.64 million +4.0%12.7%11.4 $16.70
6/30/202337,820,000 shares $655.80 million +9.6%12.2%11.1 $17.34
6/15/202334,510,000 shares $645.68 million +10.1%11.2%9.2 $18.71
5/31/202331,350,000 shares $623.24 million -15.8%10.2%8.9 $19.88
5/15/202337,210,000 shares $885.97 million +1.2%12.1%10.5 $23.81
4/30/202336,780,000 shares $892.65 million -0.4%17.2%13.7 $24.27
4/15/202336,940,000 shares $1.05 billion -2.7%17.4%13.7 $28.46
3/31/202337,960,000 shares $901.55 million +2.1%17.9%14.3 $23.75
3/15/202337,170,000 shares $888.73 million +11.0%17.6%17.1 $23.91
2/28/202333,490,000 shares $710.32 million +2.4%16.0%16.5 $21.21
2/15/202332,720,000 shares $772.19 million +8.1%15.7%17.6 $23.60
1/31/202330,260,000 shares $658.46 million +6.1%14.5%15.7 $21.76
1/15/202328,520,000 shares $565.55 million +3.0%13.7%15.6 $19.83
12/30/202227,690,000 shares $446.92 million +10.5%13.3%15.1 $16.14
12/15/202225,060,000 shares $431.03 million +11.3%12.0%13.9 $17.20
11/30/202222,520,000 shares $395.45 million -2.9%10.8%10.8 $17.56
11/15/202223,190,000 shares $435.74 million -3.5%11.1%11.1 $18.79
10/31/202224,030,000 shares $477.00 million +5.8%11.5%10.6 $19.85
10/15/202222,720,000 shares $481.21 million +4.0%10.9%9.7 $21.18
9/30/202221,850,000 shares $511.73 million -0.3%10.5%9 $23.42
9/15/202221,920,000 shares $546.90 million +3.0%10.5%8.8 $24.95
8/31/202221,290,000 shares $442.41 million +12.5%10.2%9.5 $20.78
8/15/202218,920,000 shares $440.84 million -3.0%9.1%7.9 $23.30
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad)

When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker.tc pixel

See the stock Musk's own words pointed to right here
7/31/202219,500,000 shares $488.09 million +1.8%10.1%8.4 $25.03
7/15/202219,160,000 shares $505.63 million -12.8%10.0%8.6 $26.39
6/30/202221,970,000 shares $479.61 million +9.7%11.4%10.6 $21.83
6/15/202220,030,000 shares $380.97 million -2.1%10.4%10.4 $19.02
5/31/202220,460,000 shares $390.79 million -0.5%10.7%10.2 $19.10
5/15/202220,560,000 shares $394.14 million +20.2%10.7%11.4 $19.17
4/30/202217,100,000 shares $303.87 million +11.1%9.1%10.1 $17.77
4/15/202215,390,000 shares $355.05 million +5.3%8.2%8.7 $23.07
3/31/202214,620,000 shares $370.62 million -5.5%8.1%7.9 $25.35
3/15/202215,470,000 shares $305.53 million +8.3%8.5%7.6 $19.75
2/28/202214,290,000 shares $288.94 million +8.4%7.9%6.3 $20.22
2/15/202213,180,000 shares $288.25 million -5.8%7.4%5.9 $21.87
1/31/202213,990,000 shares $231.95 million +8.1%7.9%6.3 $16.58
1/15/202212,940,000 shares $253.75 million +1.3%7.3%6 $19.61
12/31/202112,780,000 shares $345.06 million +48.8%7.2%5.7 $27.00
12/15/20218,590,000 shares $202.21 million +57.6%4.8%4 $23.54
11/30/20215,450,000 shares $119.90 million +51.8%3.1%3.2 $22.00
11/15/20213,590,000 shares $90.97 million +38.1%2.1%2.5 $25.34
10/29/20212,600,000 shares $63.70 million -55.9%1.5%2 $24.50
10/15/20215,900,000 shares $141.36 million +7.3%3.4%5.5 $23.96
9/30/20215,500,000 shares $144.16 million +34.2%3.2%8.2 $26.21
9/15/20214,100,000 shares $127.18 million -23.5%2.4%6.5 $31.02
8/31/20215,360,000 shares $187.60 million +12.1%3.4%9.2 $35.00
8/13/20214,780,000 shares $167.44 million No Change3.0%7.6 $35.03

AGL Short Interest - Frequently Asked Questions

Short interest is the volume of Agilon Health shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 791,524 shares of AGL short. 4.86% of Agilon Health's shares are currently sold short. Learn More on Agilon Health's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AGL shares currently have a short interest ratio of 1.9. Learn More on Agilon Health's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.86% of Agilon Health's floating shares are currently sold short.

Agilon Health saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 791,524 shares, a drop of 20.9% from the previous total of 1,000,735 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

4.86% of Agilon Health's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Agilon Health: Veracyte, Inc. (8.73%), Option Care Health, Inc. (7.09%), Concentra Group Holdings Parent, Inc. (2.45%), LifeStance Health Group, Inc. (1.91%), Privia Health Group, Inc. (2.69%), GRAIL, Inc. (16.57%), Heartflow, Inc. (5.48%), Definium Therapeutics, Inc. (9.60%), Surgery Partners, Inc. (12.42%), Addus HomeCare Corporation (4.81%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling AGL is an investing strategy that aims to generate trading profit from Agilon Health as its price is falling. AGL shares are trading down $0.73 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Agilon Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AGL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AGL, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AGL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSE:AGL) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
To Avoid 67 Million Blackouts, Trump Signs Emergency Backing of New Energy Tech
President Trump has used emergency executive powers to back a new energy technology described as 326 times mor...
Altimetry | Sponsoredtc pixel
Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...
InvestorPlace | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel